Asa Abeliovich
Presidente presso Leal Therapeutics, Inc.
Profilo
Asa Abeliovich is the founder of Alector, Inc. (founded in 2013) and Prevail Therapeutics, Inc. (founded in 2017).
At Alector, Inc., he held the title of Principal from 2013 to 2017.
At Prevail Therapeutics, Inc., he held the titles of President, Chief Executive Officer & Director.
Dr. Abeliovich's current job is as President, Treasurer, Secretary & Director at Leal Therapeutics, Inc. Dr. Abeliovich's former jobs include Principal at Genentech, Inc., Associate Professor at The Trustees of Columbia University in The City of New York, and Member at Taub Institute For Research on Alzheimer's Disease & The Aging (held from 2000 to 2017).
Dr. Abeliovich's education includes an undergraduate degree and a doctorate from Massachusetts Institute of Technology and a doctorate from Harvard Medical School.
Posizioni attive di Asa Abeliovich
| Società | Posizione | Inizio |
|---|---|---|
Leal Therapeutics, Inc.
 Leal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Leal Therapeutics, Inc. develops novel therapeutics for patients with major disorders of the central nervous systems. | Presidente | - |
Precedenti posizioni note di Asa Abeliovich
| Società | Posizione | Fine |
|---|---|---|
| ALECTOR, INC. | Fondatore | 01/12/2017 |
| Taub Institute For Research on Alzheimer's Disease & The Aging | Corporate Officer/Principal | 01/10/2017 |
| PREVAIL THERAPEUTICS INC. | Fondatore | - |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formazione di Asa Abeliovich
| Harvard Medical School | Doctorate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALECTOR, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Prevail Therapeutics, Inc.
 Prevail Therapeutics, Inc. BiotechnologyHealth Technology Prevail Therapeutics, Inc. develops therapeutics for neurodegenerative diseases. The firm engages in the research and development of novel biologic gene therapies to treat Parkinson's disease and other neurodegenerative diseases. The company was founded by Asa Abeliovich on July 6, 2017 and is headquartered in New York, NY. | Health Technology |
| Taub Institute For Research on Alzheimer's Disease & The Aging | |
Leal Therapeutics, Inc.
Leal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Leal Therapeutics, Inc. develops novel therapeutics for patients with major disorders of the central nervous systems. | Commercial Services |
- Borsa valori
- Insiders
- Asa Abeliovich
